Eric Lander, human genome project leader, weighs in on Supreme Court gene patenting case

Boston Globe: Late last year, the nation’s highest court said it would consider a legal challenge to patents that biotechnology company Myriad Genetics holds on genes linked to risk of breast cancer. Now, Eric Lander—a leader in the human genome project, a scientific adviser to President Obama, and the head of the Broad Institute in Cambridge—has weighed in, filing an amicus brief.